PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Expanded Access IND Cleared by US FDA, page-3

  1. 4,340 Posts.
    lightbulb Created with Sketch. 6873
    He is a celb, great choice for mass media attention wouldn't you say? Better than paying an advertising/marketing company in my opinion.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.